Personalized healthcare P4 cardiac health and wellness monitoring system and method utilizing TMAO and troponin
US11391743B2 · kind B2 · utility
Inventor
Key dates
| Filing date | Apr 4, 2019 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Apr 4, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4712
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The claimed invention provides real-time and subsequent analysis personalized user based caradiac health and wellness detection information utilizing novel cardiac health markers including Troponin as well as TMAO. Non-invasive techniques utilize saliva for body levels of cardiac wellness indicators as well as pharmaceutical ingestion which are coordinated over time. Saliva captured on sample strips are real-time indicator reviewed and subsequently analyzed using traditional analytical chemistry techniques including liquid chromatography/mass spectrometry (LC/MS) and coordinated with time of administration with optional genetic sequence analysis to confirm related cardiac disease conditions. By using P4 (Participatory, Personalized, Predictive, and Preventive) health management techniques the patient determines if the pharmaceutical is having the correct and desired effect for maximum therapeutic benefit. While illustrative embodiments detecting TMAO and Troponin are provided the system has broad cardiac wellness monitoring applicability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.